Burgess Hill, UK, 17.07.2008 – Roche Diagnostics Ltd. today announced that they will support the Oxford Biomedical Research Centre (OxBRC) – a partnership between the Oxford Radcliffe Hospitals NHS Trust and University of Oxford – in the development of solutions enabling improved genetic and cytogenetic testing. Using the next-generation sequencing technology of 454 Sequencing and […]

MENLO PARK, Calif., July 14 — Pacific Biosciences announced today that it has secured $100 million in a Series E private equity financing round. The proceeds will be used to fund the commercial development of the company’s innovative single-molecule, real-time (SMRT(TM)) DNA sequencing platform. The transaction was co-led by Deerfield Capital Management and Intel Capital, […]

PENZBERG, Germany–The Cancer Genomics Group at Barts and The London Medical School is researching leukemia with the aquisition of the state-of-the-art Genome Sequencer FLX System paired with the Roche NimbleGen Sequence Capture arrays. Researchers, led by Professor Brian Young, will use the combined technology of 454 Sequencing and NimbleGen Sequence Capture Arrays to uncover the […]

Aarhus Denmark – Jul 3, 2008 (PRN): Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio’s Next Generation Sequencing solution, CLC Genomics Workbench. The site license covers all researchers at all BGI sites, both inside and outside of China. Head of Bioinformatics Division at BGI, Ruiqiang Li states, ’We have […]

Roche Genome Sequencer FLX System Creates New Opportunities for HLA Research at the Blood Centre Linz, Austria PENZBERG, Germany–The Blood Centre Linz, Austria has purchased a Genome Sequencer FLX System from Roche, for use in research on rejection reactions in Bone Marrow and Stem Cell transplantation. Using conventional Sanger sequencing it can take weeks to […]

CAMBRIDGE, Mass.–Helicos BioSciences (NASDAQ:HLCS – News), a life science company focused on innovative genetic analysis technologies, announced today that it has entered into a scientific collaboration with the Children’s Oncology Group (COG) in order to interrogate a wide spectrum of genomic variation within various sarcomas, an aggressive type of bone or soft tissue cancer usually […]

OMAHA, Neb., June 17 — Transgenomic (OTC Bulletin Board: TBIO) today announced that it is developing SURVEYOR Endonuclease Adaptor-ligated Libraries (SEAL). A cost-effective and high throughput enabling technology for whole genome analysis, SEAL identifies DNA variations between a reference genome and a test genome. SEAL is designed to recognize point mutations and small insertion/deletions at […]

BRANFORD, Conn.–454 Life Sciences, a company of Roche, announces that researchers from Bielefeld University in Germany have used a single sequencing run, generated during the installation of their new Genome Sequencer FLX System, to completely assemble and characterize the genome of Corynebacterium kroppenstedtii. The whole genome analysis, led by Andreas Tauch, revealed that lipophilism is […]

Biotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation FOSTER CITY, Calif.–Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a […]

Continuing Roche’s Commitment to Support Human Genomic Research, 454 Sequencing Will Deliver Results of the Highest Quality and Completeness to International Research Effort BRANFORD, Conn.–Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to […]